Hims & Hers faces lawsuit over allegedly deceptive weight loss medication sales.
PorAinvest
lunes, 4 de agosto de 2025, 8:51 am ET1 min de lectura
HIMS--
The complaint alleges that during the class period, Hims & Hers Health Inc. issued materially false and/or misleading statements and failed to disclose that:
1. The company was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk" [2].
2. There was a substantial risk that the company's collaboration with Novo Nordisk would be terminated.
3. Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders are encouraged to contact the Gross Law Firm before August 25, 2025, to discuss their rights [1]. The firm offers portfolio monitoring software to provide shareholders with status updates throughout the case's lifecycle. There is no cost or obligation to participate in the case.
The Gross Law Firm is a nationally recognized class action law firm committed to protecting investors' rights. The firm seeks recovery on behalf of shareholders who incurred losses due to false and/or misleading statements or the omission of material information [1].
References:
[1] https://www.prnewswire.com/news-releases/hims--hers-health-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-august-25-2025-to-discuss-your-rights--hims-302520050.html
[2] https://www.marketscreener.com/news/hims-hers-health-inc-sued-for-securities-law-violations-contact-the-gross-law-firm-before-augu-ce7c5edadf8bfe20
NVO--
The Gross Law Firm is seeking shareholders of Hims & Hers Health to contact them regarding possible lead plaintiff appointment. The firm alleges that the company issued false and/or misleading statements during the class period of April 29, 2025 to June 23, 2025, including deceptive promotion and selling of illegitimate versions of Wegovy and a substantial risk that the company's collaboration with Novo Nordisk would be terminated. Shareholders are encouraged to contact the firm regarding possible lead plaintiff appointment.
NEW YORK, Aug. 4, 2025 /PRNewswire/ — The Gross Law Firm has issued a notice to shareholders of Hims & Hers Health Inc. (NYSE: HIMS), alleging securities law violations. The firm is seeking shareholders who purchased shares during the class period from April 29, 2025, to June 23, 2025, to contact them regarding possible lead plaintiff appointment [1].The complaint alleges that during the class period, Hims & Hers Health Inc. issued materially false and/or misleading statements and failed to disclose that:
1. The company was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk" [2].
2. There was a substantial risk that the company's collaboration with Novo Nordisk would be terminated.
3. Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders are encouraged to contact the Gross Law Firm before August 25, 2025, to discuss their rights [1]. The firm offers portfolio monitoring software to provide shareholders with status updates throughout the case's lifecycle. There is no cost or obligation to participate in the case.
The Gross Law Firm is a nationally recognized class action law firm committed to protecting investors' rights. The firm seeks recovery on behalf of shareholders who incurred losses due to false and/or misleading statements or the omission of material information [1].
References:
[1] https://www.prnewswire.com/news-releases/hims--hers-health-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-august-25-2025-to-discuss-your-rights--hims-302520050.html
[2] https://www.marketscreener.com/news/hims-hers-health-inc-sued-for-securities-law-violations-contact-the-gross-law-firm-before-augu-ce7c5edadf8bfe20
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios